Home › Borstkanker › Minnesota › Saint Paul
Borstkanker klinische studies in Saint Paul, MN
12 studies voor Borstkanker zoeken deelnemers op locaties in en rond Saint Paul (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruterenObservatieonderzoekGezonde vrijwilligers welkom
- Regions Hospital, Saint Paul
- United Hospital, Saint Paul
- Minnesota Oncology Hematology PA-Maplewood, Maplewood · 5 mijl verwijderd
- en nog 3
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
RekruterenFase 2
- Health Partners Cancer Center at Regions Hospital, Saint Paul
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
RekruterenFase 3
- Research Site, Saint Paul
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
RekruterenFase 3
- Healthpartners Regions Specialty Clinics, Saint Paul
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
RekruterenFase 1/2
- Metro-Minnesota Community Oncology Research Consortium, Saint Paul
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
RekruterenFase 3
- Regions Hospital, Saint Paul
- United Hospital, Saint Paul
- Minnesota Oncology Hematology PA-Maplewood, Maplewood · 5 mijl verwijderd
- en nog 3
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
RekruterenFase 1/2
- USOR Minnesota Oncology Hematology, Maplewood · 5 mijl verwijderd
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
RekruterenFase 3
- Minnesota Oncology Hematology, P.A., Maplewood · 5 mijl verwijderd
- Minnesota Oncology Hematology, P.A., Woodbury · 7 mijl verwijderd
Axelopran for Advanced Cancer in Patients Receiving Opioids
RekruterenFase 2
- HealthPartners Cancer Center at Regions Hospital, Saint Paul
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
RekruterenFase 3
- Regions Hospital, Saint Paul
- United Hospital, Saint Paul
- Minnesota Oncology Hematology PA-Maplewood, Maplewood · 5 mijl verwijderd
- en nog 2
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
RekruterenObservatieonderzoek
- Regions Hospital, Saint Paul
- United Hospital, Saint Paul
- Minnesota Oncology Hematology PA-Maplewood, Maplewood · 5 mijl verwijderd
- en nog 3
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
RekruterenFase 3
- Regions Hospital, Saint Paul
- United Hospital, Saint Paul
- Minnesota Oncology Hematology PA-Maplewood, Maplewood · 5 mijl verwijderd
- en nog 1
Borstkanker studies in andere steden
- New York City, NY136 studies
- Houston, TX126 studies
- Boston, MA112 studies
- Nashville, TN81 studies
- Los Angeles, CA73 studies
- Edison, NJ68 studies
- St. Louis, MO64 studies
- Queens, NY64 studies
- Durham, NC64 studies
- Chicago, IL59 studies
- Philadelphia, PA56 studies
- Dallas, TX55 studies
Andere studies in Saint Paul
- Niet-kleincellige longkanker19 studies
- Prostaatkanker13 studies
- Longkanker13 studies
- Colorectale kanker9 studies
- Eierstokkanker8 studies
- Metastatische kanker7 studies
- Nierkanker (niercelcarcinoom)7 studies
- Endometriumkanker6 studies
- Blasenkanker6 studies
- Melanoom6 studies
- Plaveiselcelcarcinoom van hoofd en hals6 studies
- Acute myeloïde leukemie6 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.